10-121592803-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_022970.4(FGFR2):c.109+906T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.584 in 151,896 control chromosomes in the GnomAD database, including 26,097 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.58 ( 26097 hom., cov: 31)
Consequence
FGFR2
NM_022970.4 intron
NM_022970.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.827
Publications
333 publications found
Genes affected
FGFR2 (HGNC:3689): (fibroblast growth factor receptor 2) The protein encoded by this gene is a member of the fibroblast growth factor receptor family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein consists of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member is a high-affinity receptor for acidic, basic and/or keratinocyte growth factor, depending on the isoform. Mutations in this gene are associated with Crouzon syndrome, Pfeiffer syndrome, Craniosynostosis, Apert syndrome, Jackson-Weiss syndrome, Beare-Stevenson cutis gyrata syndrome, Saethre-Chotzen syndrome, and syndromic craniosynostosis. Multiple alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2009]
FGFR2 Gene-Disease associations (from GenCC):
- Apert syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, PanelApp Australia, G2P, Genomics England PanelApp
- Beare-Stevenson cutis gyrata syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, Genomics England PanelApp
- Crouzon syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, ClinGen, PanelApp Australia, Genomics England PanelApp, G2P
- Jackson-Weiss syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, G2P
- LADD syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- Pfeiffer syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp, G2P
- Antley-Bixler syndrome without genital anomalies or disordered steroidogenesisInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, G2P
- bent bone dysplasia syndrome 1Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
- familial scaphocephaly syndrome, McGillivray typeInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
- Saethre-Chotzen syndromeInheritance: AD Classification: STRONG Submitted by: PanelApp Australia, Genomics England PanelApp
- Antley-Bixler syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- LADD syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Pfeiffer syndrome type 1Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Pfeiffer syndrome type 2Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Pfeiffer syndrome type 3Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 10-121592803-A-G is Benign according to our data. Variant chr10-121592803-A-G is described in ClinVar as Benign. ClinVar VariationId is 36931.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.67 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FGFR2 | ENST00000457416.7 | c.109+906T>C | intron_variant | Intron 2 of 17 | 1 | NM_022970.4 | ENSP00000410294.2 | |||
| FGFR2 | ENST00000358487.10 | c.109+906T>C | intron_variant | Intron 2 of 17 | 1 | NM_000141.5 | ENSP00000351276.6 | |||
| FGFR2 | ENST00000369056.5 | c.109+906T>C | intron_variant | Intron 1 of 16 | 1 | ENSP00000358052.1 | ||||
| FGFR2 | ENST00000369058.7 | c.109+906T>C | intron_variant | Intron 2 of 16 | 1 | ENSP00000358054.3 | ||||
| FGFR2 | ENST00000613048.4 | c.109+906T>C | intron_variant | Intron 2 of 16 | 5 | ENSP00000484154.1 | ||||
| FGFR2 | ENST00000369061.8 | c.109+906T>C | intron_variant | Intron 1 of 14 | 1 | ENSP00000358057.4 | ||||
| FGFR2 | ENST00000369059.5 | c.109+906T>C | intron_variant | Intron 2 of 15 | 5 | ENSP00000358055.1 | ||||
| FGFR2 | ENST00000360144.7 | c.109+906T>C | intron_variant | Intron 2 of 16 | 2 | ENSP00000353262.3 | ||||
| FGFR2 | ENST00000604236.5 | n.109+906T>C | intron_variant | Intron 2 of 16 | 1 | ENSP00000474109.1 |
Frequencies
GnomAD3 genomes AF: 0.584 AC: 88710AN: 151778Hom.: 26072 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
88710
AN:
151778
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.584 AC: 88779AN: 151896Hom.: 26097 Cov.: 31 AF XY: 0.583 AC XY: 43295AN XY: 74216 show subpopulations
GnomAD4 genome
AF:
AC:
88779
AN:
151896
Hom.:
Cov.:
31
AF XY:
AC XY:
43295
AN XY:
74216
show subpopulations
African (AFR)
AF:
AC:
21555
AN:
41404
American (AMR)
AF:
AC:
8999
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
AC:
1999
AN:
3472
East Asian (EAS)
AF:
AC:
3564
AN:
5170
South Asian (SAS)
AF:
AC:
3135
AN:
4808
European-Finnish (FIN)
AF:
AC:
6095
AN:
10540
Middle Eastern (MID)
AF:
AC:
166
AN:
292
European-Non Finnish (NFE)
AF:
AC:
41632
AN:
67936
Other (OTH)
AF:
AC:
1238
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1873
3746
5618
7491
9364
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
754
1508
2262
3016
3770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2311
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
FGFR2-related craniosynostosis Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.